Low molecular weight proteins and enzymes in the urine of patients with bladder cancer - a pilot study

about

Low molecular weight proteins and enzymes in the urine of patients with bladder cancer - a pilot study

Item

http://www.wikidata.org/entity/Q58578855

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Low molecular weight proteins ...... bladder cancer - a pilot study

@en

Low molecular weight proteins ...... bladder cancer - a pilot study

@nl

type

Item

label

Low molecular weight proteins ...... bladder cancer - a pilot study

@en

Low molecular weight proteins ...... bladder cancer - a pilot study

@nl

prefLabel

Low molecular weight proteins ...... bladder cancer - a pilot study

@en

Low molecular weight proteins ...... bladder cancer - a pilot study

@nl

P1476

Low molecular weight proteins ...... bladder cancer - a pilot study

@en

P2093

Agnieszka Piwowar

http://www.w3.org/2001/XMLSchema#string

Anna Długosz

http://www.w3.org/2001/XMLSchema#string

Beata Szymańska

http://www.w3.org/2001/XMLSchema#string

Janusz Dembowski

http://www.w3.org/2001/XMLSchema#string

Zofia Marchewka

http://www.w3.org/2001/XMLSchema#string

P2860

Nutrients Impact the Pathogenesis and Development of Colorectal Cancer

KIM-1 and NGAL as potential biomarkers for the diagnosis and cancer progression

Oxidative stress, inflammation, and cancer: how are they linked?

Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.

Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.

Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.

Tumor markers in clinical practice: General principles and guidelines.

Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer.

Evaluation of MMP-2, MMP-9, TIMP-1, TIMP-2, NGAL and MMP-9/NGAL complex in urine and sera from patients with bladder cancer.

The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment.

P304

280-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5173/CEJU.2018.1661

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30386648

http://www.w3.org/2001/XMLSchema#string

P932

6202615

http://www.w3.org/2001/XMLSchema#string